Alkermes ALKS
NASDAQ ALKS
$46.17 +0.27 (+0.59%)
At close: Nov 9, 2026 · 4:00 PM EST

Alkermes (ALKS) Acquisitions (2011 - 2026)

Updated

Alkermes (ALKS) reported Acquisitions of $8.88 million for FY2019.

Analysis

Alkermes (ALKS) Acquisitions (2011 - 2026) Analysis & Trends

  • The FY2019 figure ranks as the highest annual Acquisitions since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -17.15 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 10.59 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Alkermes 7.77 Bn 5.26 Bn 385.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.09 Bn
Dec 31, 2011 -188,000.00
API Access

Alkermes Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ALKS&period=max&api_key=YOUR_API_KEY